| n = 58 |
---|---|
Age (years) | 55 ± 15 |
Male sex, n (%) | 46 (79) |
Ethnicity, n (%) | |
 White | 24 (41.4) |
 Asian | 28 (48.3) |
 Black, Mixed, Other | 6 (10.3) |
BMI (kg/m2) | 26.4 (23.0; 29.7) |
Systolic blood pressure (mmHg) | 144.0 ± 39.5 |
Diastolic blood pressure (mmHg) | 64.7 ± 16.8 |
Active on transplant list | 18 (31) |
Previous transplant, n (%) | 18 (31) |
Total RRT time (months) | 32.0 (11.8; 95.0) |
Haemodialysis vintage (months) | 21.0 (8.0; 48.3) |
Comorbidities | |
 Coronary artery disease | 15 (25.9) |
 Previous myocardial infarction | 9 (15.5) |
 Coronary revascularisation | 7 (12.1) |
 Hypertension | 37 (63.8) |
 Diabetes mellitus | 24 (41.4) |
 Dyslipidaemia | 13 (22.4) |
 Heart failure | 0 |
 Peripheral vascular disease | 0 |
 Atrial fibrillation | 2 (3.4) |
 Cerebrovascular disease | 2 (3.4) |
 Asthma/COPD | 0 |
CMR parameters | |
 Global native T1 rest (ms) | 1261 ± 57 |
 Global native T1 stress (ms) | 1297 ± 50 |
 Myocardial ΔT1 (%) | 2.9 ± 2.5 |
 LV mass index (g/m2) | 60.1 (52.8; 76.8) |
 LV end-diastolic volume index (ml/m2) | 87.6 (67.6; 116.5) |
 LV end-systolic volume index (ml/m2) | 37.6 (26.9; 51.6) |
 LV ejection fraction (%) | 54.8 ± 8.3 |
 LV mass / LV end-diastolic volume | 0.73 ± 0.17 |